Abiopharma

🔍 UNANUE CARLOS (Executive)

Company: POPULAR, INC. (BPOP)

Report Date: 2026-05-08

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock Par Value $0.01 per share (Direct)
  Date: 2026-05-08 | Code: H | shares_owned_after: 58,878.82
• Holds 0 shares of Common Stock Par Value $0.01 per share (Direct)
  Date: 2026-05-08 | Code: H | nature_of_ownership: By mother | shares_owned_after: 75,731.00 | Footnotes: F1
• Acquired 1,477 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-08 | Code: A | equity_swap_involved: false | shares_owned_after: 26,950.00 | transaction_form_type: 4 | Footnotes: F2, F3, F4, F4

Footnotes:

• F1: The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
• F2: Restricted stock units convert into common stock on a one-for-one basis.
• F3: Award of restricted stock units pursuant to Popular, Inc.'s 2020 Omnibus Incentive Plan. The award vests on May 8, 2027.
• F4: Restricted stock units are converted into an equivalent number of shares of common stock and issued to the reporting person in equal annual installments on each 15th of August of the first five years following the date of termination of service as a director.